The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
The company returns high margins, thereby supporting business profitability.
The company is in a robust financial situation considering its net cash and margin position.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
The stock is in a well-established, long-term rising trend above the technical support level at 233.4 EUR
Weaknesses
Based on current prices, the company has particularly high valuation levels.
With an expected P/E ratio at 83.29 and 67.89 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company is not the most generous with respect to shareholders' compensation.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
Ratings chart
Sector Medical Equipment, Supplies & Distribution - NEC
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
